Triarylmethanes, a new class of Cx50 inhibitors
The paucity of specific pharmacological agents has been a major impediment for delineating the roles of gap junction channels formed by connexin proteins in physiology and pathophysiology. Here, we used the selective optimization of side activities (SOSA) approach, which has led to the design of hig...
Saved in:
Main Authors: | SILKE eBODENDIEK (Author), CLIO eRUBINOS (Author), MARIA PILAR TRELLES (Author), DAVID eJENKINS (Author), NICHOLE eCOLEMAN (Author), Heike eWulff (Author), MIDUTURU eSRINIVAS (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Variability of FEV1 and Criterion for Acute Pulmonary Exacerbation
by: Bradlee eJenkins, et al.
Published: (2014) -
Neurological manifestations of oculodentodigital dysplasia: a Cx43 channelopathy of the central nervous system?
by: Marijke eDe Bock, et al.
Published: (2013) -
The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies
by: Hae Jung eChon, et al.
Published: (2015) -
Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
by: Piotr Wojdasiewicz, et al.
Published: (2019) -
Keeping Meta-Analyses Hygienic During the COVID-19 Pandemic
by: Jordane Boudesseul, et al.
Published: (2021)